Building Confidence in PGx

This CPD webinar goes beyond the basics of PGx, helping prescribers make sense of metabolic types and their impact on dosing. You’ll gain practical guidance on interpreting phenotypes and applying recommendations to reduce trial-and-error prescribing in complex cases.

23 September 2025

Time: 12pm

Duration: 45 mins

Audience

Doctors Doctors

Pharmacists

Getting the Most Out of PGx Guided Prescriptions

We often hear from GPs and prescribers that the challenge with PGx isn’t knowing the science—it’s knowing how to interpret the reports with confidence. Clinicians tell us they want more clarity on what a “poor,” “intermediate,” or “ultra-rapid” metaboliser result really means for dosing, and how to apply those insights across antidepressants, painkillers, statins, and other common medicines.

This webinar responds directly to that need. Through practical, case-based examples, we’ll walk step by step through real PGx reports, explain how to interpret different phenotypes, and show how to translate those findings into safe, effective prescribing.

As primary care takes on more complex cases—particularly in mental health, chronic pain, and polypharmacy—PGx is becoming an essential tool to reduce trial-and-error, improve adherence, and support shared decision-making. With NHS interest in personalised prescribing accelerating, now is the time to build the confidence to put PGx into everyday practice.